about
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.Update on ablative therapies of renal tumors.Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy.Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Pelvis: A Case ReportDevelopment of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.Characteristics and clinical significance of histological variants of bladder cancer.Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer.Biomarkers for immunotherapy in urological cancers.Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer.Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementA systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimensPrognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaborationImpact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerAssociation of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalizationPredictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?Role of serum cholinesterase in patients treated with salvage radical prostatectomyThe prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancerDiagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancerDifferences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaborationEndocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literatureDevelopment of a prognostic model for survival time prediction in castration-resistant prostate cancer patientsPropensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomyClinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomyComparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study
P50
Q38831584-E224D5B2-7ED8-4894-8607-406F96DEA6AAQ38841867-CE0F0D68-5F42-470C-B895-C7B07EB88FC9Q38978287-BC8012BA-74D5-45B6-9D68-51D3B8354FD5Q39010863-483F561C-3902-4005-9B35-D1BD939B20E2Q39046515-40459131-BADB-4E52-B285-E7F71F222101Q40968507-23E7C02F-7BC1-4415-B5AA-7297DCA03C7FQ41512697-5757ECDE-6AAA-43C1-83FC-9535178B20EFQ47998264-8A246033-2B64-4176-AC95-A851611D2668Q49486672-7D52E075-7F30-436C-84D6-F74F3EB68D6AQ49508672-FE0F92A0-3E47-44BC-BF7B-475CFABE5B09Q49844303-DE3985A7-33FF-4A1D-AA7C-95B6D04D47C1Q50094088-378721DE-6720-489B-9A60-D0690C2BAB3DQ50278708-DC893353-E350-42AB-A012-C5A5C9835AE4Q52760819-859AEF51-C78C-4CCD-A29B-71ABB5DE7D38Q52775564-45911C9F-EA96-4223-959E-A2ABA159F95CQ53051702-BD842904-8F55-419A-A749-4E0BDAE3E035Q54187420-A0A69382-93B0-4F90-86EF-3860E50EE933Q88283579-F3B1CF4F-7C9E-47BF-857B-E09E9F856BF2Q88883211-92FBE5D0-5CB3-49A1-A703-184ACBF8920CQ89615469-6BD84AA4-126D-4BC5-B660-133261678926Q89712370-4BB5374E-22F9-4ABC-AB33-F33B7DFBFCF9Q90043400-097465BF-A3BF-45BB-BFFF-340F3B202973Q90129680-2D14CAB0-351D-4922-B5E3-63E9AB4ABEA0Q90315155-4906A28B-4742-459C-B2B1-89FFCF8FB728Q90627464-446F5CE5-126A-45DA-A9A2-6D477FEAE678Q90726245-E01B8AE2-1C40-42F0-93EF-B42FB9FE6A92Q91090679-D828B857-15A2-4CBA-A809-A119213D6FC0Q91766029-9FABB080-BEDF-40C2-8C2F-D582930A2E76Q92204688-1F660596-D34B-466B-A161-9634E6243760Q92737324-5F041BF5-AB13-4267-9076-13D372807C4AQ93182623-2FA9CBEF-EC4D-44E6-90DB-91E17BD44795Q93182737-682DAADE-DEF7-40BC-B4CB-C3E727A8AF5EQ93220405-BD143EC9-1859-40C1-80B1-D939BFEC0821
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David D'Andrea
@ast
David D'Andrea
@en
David D'Andrea
@es
David D'Andrea
@nl
David D'Andrea
@sl
type
label
David D'Andrea
@ast
David D'Andrea
@en
David D'Andrea
@es
David D'Andrea
@nl
David D'Andrea
@sl
prefLabel
David D'Andrea
@ast
David D'Andrea
@en
David D'Andrea
@es
David D'Andrea
@nl
David D'Andrea
@sl
P106
P1153
57190510664
P21
P31
P496
0000-0003-1625-1077